Laparoscopic renal sympathetic denervation was found to be a safe and potentially effective treatment for refractory hypertension in patients with end-stage renal disease.
Does laparoscopic-based renal sympathetic denervation improve refractory hypertension in patients with end-stage renal disease?
Laparoscopic renal denervation may offer a viable alternative for treating refractory hypertension in ESRD patients who cannot undergo standard intravascular procedures.
Absolute Event Rate: 0% vs 0%
This case series demonstrates that L-RDN may represent a safe and effective therapeutic modality, offering a potential alternative treatment option for patients with vascular pathologies or contraindications to intravascular interventions. However, given the limited sample size, further prospective studies are necessary to validate its long-term efficacy and safety.
Wang et al. (Mon,) reported a other. Laparoscopic renal sympathetic denervation was found to be a safe and potentially effective treatment for refractory hypertension in patients with end-stage renal disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: